Fig. 6From: An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancerAnalysis of the m6A-RLPS stratified by risk level. Kaplan–Meier curves for the m6A-RLPS in the (a) training and (d) validation cohorts. Distributions of risk scores, survival status, and relative lncRNA expressions in the (b) training and (e) validation cohorts. ROC curves for predicting 1-, 3-, and 5-year OS rates in the (c) training and (f) validation datasetsBack to article page